Global Atezolizumab Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Atezolizumab Industry Forecast” looks at past sales and reviews total world Atezolizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Atezolizumab sales for 2023 through 2029. With Atezolizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atezolizumab industry.
This Insight Report provides a comprehensive analysis of the global Atezolizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atezolizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Atezolizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atezolizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atezolizumab.
The global Atezolizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Atezolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Atezolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Atezolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Atezolizumab players cover Genentech (Roche). etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Atezolizumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Atezolizumab market?
What factors are driving Atezolizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atezolizumab market opportunities vary by end market size?
How does Atezolizumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Atezolizumab Industry Forecast” looks at past sales and reviews total world Atezolizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Atezolizumab sales for 2023 through 2029. With Atezolizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atezolizumab industry.
This Insight Report provides a comprehensive analysis of the global Atezolizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atezolizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Atezolizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atezolizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atezolizumab.
The global Atezolizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Atezolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Atezolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Atezolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Atezolizumab players cover Genentech (Roche). etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Atezolizumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Use: Single Drug
- Use: Chemotherapy Combination
- Bladder Cancer
- Lung Cancer
- Advanced Triple-negative Breast Cancer
- Head and Neck Cancer
- Urothelial Carcinoma
- Renal Cell Carcinoma
- Hepatocellular Carcinoma (HCC)
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Genentech (Roche)
What is the 10-year outlook for the global Atezolizumab market?
What factors are driving Atezolizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atezolizumab market opportunities vary by end market size?
How does Atezolizumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Atezolizumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Atezolizumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Atezolizumab by Country/Region, 2018, 2022 & 2029
2.2 Atezolizumab Segment by Type
2.2.1 Use: Single Drug
2.2.2 Use: Chemotherapy Combination
2.3 Atezolizumab Sales by Type
2.3.1 Global Atezolizumab Sales Market Share by Type (2018-2023)
2.3.2 Global Atezolizumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Atezolizumab Sale Price by Type (2018-2023)
2.4 Atezolizumab Segment by Application
2.4.1 Bladder Cancer
2.4.2 Lung Cancer
2.4.3 Advanced Triple-negative Breast Cancer
2.4.4 Head and Neck Cancer
2.4.5 Urothelial Carcinoma
2.4.6 Renal Cell Carcinoma
2.4.7 Hepatocellular Carcinoma (HCC)
2.4.8 Other
2.5 Atezolizumab Sales by Application
2.5.1 Global Atezolizumab Sale Market Share by Application (2018-2023)
2.5.2 Global Atezolizumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Atezolizumab Sale Price by Application (2018-2023)
3 GLOBAL ATEZOLIZUMAB BY COMPANY
3.1 Global Atezolizumab Breakdown Data by Company
3.1.1 Global Atezolizumab Annual Sales by Company (2018-2023)
3.1.2 Global Atezolizumab Sales Market Share by Company (2018-2023)
3.2 Global Atezolizumab Annual Revenue by Company (2018-2023)
3.2.1 Global Atezolizumab Revenue by Company (2018-2023)
3.2.2 Global Atezolizumab Revenue Market Share by Company (2018-2023)
3.3 Global Atezolizumab Sale Price by Company
3.4 Key Manufacturers Atezolizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Atezolizumab Product Location Distribution
3.4.2 Players Atezolizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ATEZOLIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Atezolizumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Atezolizumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Atezolizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Atezolizumab Market Size by Country/Region (2018-2023)
4.2.1 Global Atezolizumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Atezolizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Atezolizumab Sales Growth
4.4 APAC Atezolizumab Sales Growth
4.5 Europe Atezolizumab Sales Growth
4.6 Middle East & Africa Atezolizumab Sales Growth
5 AMERICAS
5.1 Americas Atezolizumab Sales by Country
5.1.1 Americas Atezolizumab Sales by Country (2018-2023)
5.1.2 Americas Atezolizumab Revenue by Country (2018-2023)
5.2 Americas Atezolizumab Sales by Type
5.3 Americas Atezolizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Atezolizumab Sales by Region
6.1.1 APAC Atezolizumab Sales by Region (2018-2023)
6.1.2 APAC Atezolizumab Revenue by Region (2018-2023)
6.2 APAC Atezolizumab Sales by Type
6.3 APAC Atezolizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Atezolizumab by Country
7.1.1 Europe Atezolizumab Sales by Country (2018-2023)
7.1.2 Europe Atezolizumab Revenue by Country (2018-2023)
7.2 Europe Atezolizumab Sales by Type
7.3 Europe Atezolizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Atezolizumab by Country
8.1.1 Middle East & Africa Atezolizumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Atezolizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Atezolizumab Sales by Type
8.3 Middle East & Africa Atezolizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atezolizumab
10.3 Manufacturing Process Analysis of Atezolizumab
10.4 Industry Chain Structure of Atezolizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Atezolizumab Distributors
11.3 Atezolizumab Customer
12 WORLD FORECAST REVIEW FOR ATEZOLIZUMAB BY GEOGRAPHIC REGION
12.1 Global Atezolizumab Market Size Forecast by Region
12.1.1 Global Atezolizumab Forecast by Region (2024-2029)
12.1.2 Global Atezolizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Atezolizumab Forecast by Type
12.7 Global Atezolizumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Genentech (Roche)
13.1.1 Genentech (Roche) Company Information
13.1.2 Genentech (Roche) Atezolizumab Product Portfolios and Specifications
13.1.3 Genentech (Roche) Atezolizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Genentech (Roche) Main Business Overview
13.1.5 Genentech (Roche) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Atezolizumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Atezolizumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Atezolizumab by Country/Region, 2018, 2022 & 2029
2.2 Atezolizumab Segment by Type
2.2.1 Use: Single Drug
2.2.2 Use: Chemotherapy Combination
2.3 Atezolizumab Sales by Type
2.3.1 Global Atezolizumab Sales Market Share by Type (2018-2023)
2.3.2 Global Atezolizumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Atezolizumab Sale Price by Type (2018-2023)
2.4 Atezolizumab Segment by Application
2.4.1 Bladder Cancer
2.4.2 Lung Cancer
2.4.3 Advanced Triple-negative Breast Cancer
2.4.4 Head and Neck Cancer
2.4.5 Urothelial Carcinoma
2.4.6 Renal Cell Carcinoma
2.4.7 Hepatocellular Carcinoma (HCC)
2.4.8 Other
2.5 Atezolizumab Sales by Application
2.5.1 Global Atezolizumab Sale Market Share by Application (2018-2023)
2.5.2 Global Atezolizumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Atezolizumab Sale Price by Application (2018-2023)
3 GLOBAL ATEZOLIZUMAB BY COMPANY
3.1 Global Atezolizumab Breakdown Data by Company
3.1.1 Global Atezolizumab Annual Sales by Company (2018-2023)
3.1.2 Global Atezolizumab Sales Market Share by Company (2018-2023)
3.2 Global Atezolizumab Annual Revenue by Company (2018-2023)
3.2.1 Global Atezolizumab Revenue by Company (2018-2023)
3.2.2 Global Atezolizumab Revenue Market Share by Company (2018-2023)
3.3 Global Atezolizumab Sale Price by Company
3.4 Key Manufacturers Atezolizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Atezolizumab Product Location Distribution
3.4.2 Players Atezolizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ATEZOLIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Atezolizumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Atezolizumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Atezolizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Atezolizumab Market Size by Country/Region (2018-2023)
4.2.1 Global Atezolizumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Atezolizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Atezolizumab Sales Growth
4.4 APAC Atezolizumab Sales Growth
4.5 Europe Atezolizumab Sales Growth
4.6 Middle East & Africa Atezolizumab Sales Growth
5 AMERICAS
5.1 Americas Atezolizumab Sales by Country
5.1.1 Americas Atezolizumab Sales by Country (2018-2023)
5.1.2 Americas Atezolizumab Revenue by Country (2018-2023)
5.2 Americas Atezolizumab Sales by Type
5.3 Americas Atezolizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Atezolizumab Sales by Region
6.1.1 APAC Atezolizumab Sales by Region (2018-2023)
6.1.2 APAC Atezolizumab Revenue by Region (2018-2023)
6.2 APAC Atezolizumab Sales by Type
6.3 APAC Atezolizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Atezolizumab by Country
7.1.1 Europe Atezolizumab Sales by Country (2018-2023)
7.1.2 Europe Atezolizumab Revenue by Country (2018-2023)
7.2 Europe Atezolizumab Sales by Type
7.3 Europe Atezolizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Atezolizumab by Country
8.1.1 Middle East & Africa Atezolizumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Atezolizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Atezolizumab Sales by Type
8.3 Middle East & Africa Atezolizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atezolizumab
10.3 Manufacturing Process Analysis of Atezolizumab
10.4 Industry Chain Structure of Atezolizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Atezolizumab Distributors
11.3 Atezolizumab Customer
12 WORLD FORECAST REVIEW FOR ATEZOLIZUMAB BY GEOGRAPHIC REGION
12.1 Global Atezolizumab Market Size Forecast by Region
12.1.1 Global Atezolizumab Forecast by Region (2024-2029)
12.1.2 Global Atezolizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Atezolizumab Forecast by Type
12.7 Global Atezolizumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Genentech (Roche)
13.1.1 Genentech (Roche) Company Information
13.1.2 Genentech (Roche) Atezolizumab Product Portfolios and Specifications
13.1.3 Genentech (Roche) Atezolizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Genentech (Roche) Main Business Overview
13.1.5 Genentech (Roche) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Atezolizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Atezolizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Use: Single Drug
Table 4. Major Players of Use: Chemotherapy Combination
Table 5. Global Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Atezolizumab Sales Market Share by Type (2018-2023)
Table 7. Global Atezolizumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Atezolizumab Revenue Market Share by Type (2018-2023)
Table 9. Global Atezolizumab Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Atezolizumab Sales Market Share by Application (2018-2023)
Table 12. Global Atezolizumab Revenue by Application (2018-2023)
Table 13. Global Atezolizumab Revenue Market Share by Application (2018-2023)
Table 14. Global Atezolizumab Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Atezolizumab Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Atezolizumab Sales Market Share by Company (2018-2023)
Table 17. Global Atezolizumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Atezolizumab Revenue Market Share by Company (2018-2023)
Table 19. Global Atezolizumab Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Atezolizumab Producing Area Distribution and Sales Area
Table 21. Players Atezolizumab Products Offered
Table 22. Atezolizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Atezolizumab Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Atezolizumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Atezolizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Atezolizumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Atezolizumab Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Atezolizumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Atezolizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Atezolizumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Atezolizumab Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Atezolizumab Sales Market Share by Country (2018-2023)
Table 35. Americas Atezolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Atezolizumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Atezolizumab Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Atezolizumab Sales Market Share by Region (2018-2023)
Table 41. APAC Atezolizumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Atezolizumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Atezolizumab Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Atezolizumab Sales Market Share by Country (2018-2023)
Table 47. Europe Atezolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Atezolizumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Atezolizumab Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Atezolizumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Atezolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Atezolizumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Atezolizumab
Table 58. Key Market Challenges & Risks of Atezolizumab
Table 59. Key Industry Trends of Atezolizumab
Table 60. Atezolizumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Atezolizumab Distributors List
Table 63. Atezolizumab Customer List
Table 64. Global Atezolizumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Atezolizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Atezolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Atezolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Atezolizumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Atezolizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Atezolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Atezolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Atezolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Atezolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Atezolizumab Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Atezolizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Atezolizumab Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Atezolizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Genentech (Roche) Basic Information, Atezolizumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Genentech (Roche) Atezolizumab Product Portfolios and Specifications
Table 80. Genentech (Roche) Atezolizumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Genentech (Roche) Main Business
Table 82. Genentech (Roche) Latest Developments
Table 1. Atezolizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Atezolizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Use: Single Drug
Table 4. Major Players of Use: Chemotherapy Combination
Table 5. Global Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Atezolizumab Sales Market Share by Type (2018-2023)
Table 7. Global Atezolizumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Atezolizumab Revenue Market Share by Type (2018-2023)
Table 9. Global Atezolizumab Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Atezolizumab Sales Market Share by Application (2018-2023)
Table 12. Global Atezolizumab Revenue by Application (2018-2023)
Table 13. Global Atezolizumab Revenue Market Share by Application (2018-2023)
Table 14. Global Atezolizumab Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Atezolizumab Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Atezolizumab Sales Market Share by Company (2018-2023)
Table 17. Global Atezolizumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Atezolizumab Revenue Market Share by Company (2018-2023)
Table 19. Global Atezolizumab Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Atezolizumab Producing Area Distribution and Sales Area
Table 21. Players Atezolizumab Products Offered
Table 22. Atezolizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Atezolizumab Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Atezolizumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Atezolizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Atezolizumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Atezolizumab Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Atezolizumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Atezolizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Atezolizumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Atezolizumab Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Atezolizumab Sales Market Share by Country (2018-2023)
Table 35. Americas Atezolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Atezolizumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Atezolizumab Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Atezolizumab Sales Market Share by Region (2018-2023)
Table 41. APAC Atezolizumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Atezolizumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Atezolizumab Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Atezolizumab Sales Market Share by Country (2018-2023)
Table 47. Europe Atezolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Atezolizumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Atezolizumab Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Atezolizumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Atezolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Atezolizumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Atezolizumab Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Atezolizumab Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Atezolizumab
Table 58. Key Market Challenges & Risks of Atezolizumab
Table 59. Key Industry Trends of Atezolizumab
Table 60. Atezolizumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Atezolizumab Distributors List
Table 63. Atezolizumab Customer List
Table 64. Global Atezolizumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Atezolizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Atezolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Atezolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Atezolizumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Atezolizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Atezolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Atezolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Atezolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Atezolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Atezolizumab Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Atezolizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Atezolizumab Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Atezolizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Genentech (Roche) Basic Information, Atezolizumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Genentech (Roche) Atezolizumab Product Portfolios and Specifications
Table 80. Genentech (Roche) Atezolizumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Genentech (Roche) Main Business
Table 82. Genentech (Roche) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Atezolizumab
Figure 2. Atezolizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atezolizumab Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Atezolizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Atezolizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Use: Single Drug
Figure 10. Product Picture of Use: Chemotherapy Combination
Figure 11. Global Atezolizumab Sales Market Share by Type in 2022
Figure 12. Global Atezolizumab Revenue Market Share by Type (2018-2023)
Figure 13. Atezolizumab Consumed in Bladder Cancer
Figure 14. Global Atezolizumab Market: Bladder Cancer (2018-2023) & (K Pcs)
Figure 15. Atezolizumab Consumed in Lung Cancer
Figure 16. Global Atezolizumab Market: Lung Cancer (2018-2023) & (K Pcs)
Figure 17. Atezolizumab Consumed in Advanced Triple-negative Breast Cancer
Figure 18. Global Atezolizumab Market: Advanced Triple-negative Breast Cancer (2018-2023) & (K Pcs)
Figure 19. Atezolizumab Consumed in Head and Neck Cancer
Figure 20. Global Atezolizumab Market: Head and Neck Cancer (2018-2023) & (K Pcs)
Figure 21. Atezolizumab Consumed in Urothelial Carcinoma
Figure 22. Global Atezolizumab Market: Urothelial Carcinoma (2018-2023) & (K Pcs)
Figure 23. Atezolizumab Consumed in Renal Cell Carcinoma
Figure 24. Global Atezolizumab Market: Renal Cell Carcinoma (2018-2023) & (K Pcs)
Figure 25. Atezolizumab Consumed in Hepatocellular Carcinoma (HCC)
Figure 26. Global Atezolizumab Market: Hepatocellular Carcinoma (HCC) (2018-2023) & (K Pcs)
Figure 27. Atezolizumab Consumed in Other
Figure 28. Global Atezolizumab Market: Other (2018-2023) & (K Pcs)
Figure 29. Global Atezolizumab Sales Market Share by Application (2022)
Figure 30. Global Atezolizumab Revenue Market Share by Application in 2022
Figure 31. Atezolizumab Sales Market by Company in 2022 (K Pcs)
Figure 32. Global Atezolizumab Sales Market Share by Company in 2022
Figure 33. Atezolizumab Revenue Market by Company in 2022 ($ Million)
Figure 34. Global Atezolizumab Revenue Market Share by Company in 2022
Figure 35. Global Atezolizumab Sales Market Share by Geographic Region (2018-2023)
Figure 36. Global Atezolizumab Revenue Market Share by Geographic Region in 2022
Figure 37. Americas Atezolizumab Sales 2018-2023 (K Pcs)
Figure 38. Americas Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 39. APAC Atezolizumab Sales 2018-2023 (K Pcs)
Figure 40. APAC Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 41. Europe Atezolizumab Sales 2018-2023 (K Pcs)
Figure 42. Europe Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Atezolizumab Sales 2018-2023 (K Pcs)
Figure 44. Middle East & Africa Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 45. Americas Atezolizumab Sales Market Share by Country in 2022
Figure 46. Americas Atezolizumab Revenue Market Share by Country in 2022
Figure 47. Americas Atezolizumab Sales Market Share by Type (2018-2023)
Figure 48. Americas Atezolizumab Sales Market Share by Application (2018-2023)
Figure 49. United States Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. Canada Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. Mexico Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Brazil Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 53. APAC Atezolizumab Sales Market Share by Region in 2022
Figure 54. APAC Atezolizumab Revenue Market Share by Regions in 2022
Figure 55. APAC Atezolizumab Sales Market Share by Type (2018-2023)
Figure 56. APAC Atezolizumab Sales Market Share by Application (2018-2023)
Figure 57. China Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. Japan Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. South Korea Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. Southeast Asia Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. India Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 62. Australia Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 63. China Taiwan Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 64. Europe Atezolizumab Sales Market Share by Country in 2022
Figure 65. Europe Atezolizumab Revenue Market Share by Country in 2022
Figure 66. Europe Atezolizumab Sales Market Share by Type (2018-2023)
Figure 67. Europe Atezolizumab Sales Market Share by Application (2018-2023)
Figure 68. Germany Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. France Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. UK Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 71. Italy Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 72. Russia Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 73. Middle East & Africa Atezolizumab Sales Market Share by Country in 2022
Figure 74. Middle East & Africa Atezolizumab Revenue Market Share by Country in 2022
Figure 75. Middle East & Africa Atezolizumab Sales Market Share by Type (2018-2023)
Figure 76. Middle East & Africa Atezolizumab Sales Market Share by Application (2018-2023)
Figure 77. Egypt Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 78. South Africa Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 79. Israel Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 80. Turkey Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 81. GCC Country Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Atezolizumab in 2022
Figure 83. Manufacturing Process Analysis of Atezolizumab
Figure 84. Industry Chain Structure of Atezolizumab
Figure 85. Channels of Distribution
Figure 86. Global Atezolizumab Sales Market Forecast by Region (2024-2029)
Figure 87. Global Atezolizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 88. Global Atezolizumab Sales Market Share Forecast by Type (2024-2029)
Figure 89. Global Atezolizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 90. Global Atezolizumab Sales Market Share Forecast by Application (2024-2029)
Figure 91. Global Atezolizumab Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Atezolizumab
Figure 2. Atezolizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atezolizumab Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Atezolizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Atezolizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Use: Single Drug
Figure 10. Product Picture of Use: Chemotherapy Combination
Figure 11. Global Atezolizumab Sales Market Share by Type in 2022
Figure 12. Global Atezolizumab Revenue Market Share by Type (2018-2023)
Figure 13. Atezolizumab Consumed in Bladder Cancer
Figure 14. Global Atezolizumab Market: Bladder Cancer (2018-2023) & (K Pcs)
Figure 15. Atezolizumab Consumed in Lung Cancer
Figure 16. Global Atezolizumab Market: Lung Cancer (2018-2023) & (K Pcs)
Figure 17. Atezolizumab Consumed in Advanced Triple-negative Breast Cancer
Figure 18. Global Atezolizumab Market: Advanced Triple-negative Breast Cancer (2018-2023) & (K Pcs)
Figure 19. Atezolizumab Consumed in Head and Neck Cancer
Figure 20. Global Atezolizumab Market: Head and Neck Cancer (2018-2023) & (K Pcs)
Figure 21. Atezolizumab Consumed in Urothelial Carcinoma
Figure 22. Global Atezolizumab Market: Urothelial Carcinoma (2018-2023) & (K Pcs)
Figure 23. Atezolizumab Consumed in Renal Cell Carcinoma
Figure 24. Global Atezolizumab Market: Renal Cell Carcinoma (2018-2023) & (K Pcs)
Figure 25. Atezolizumab Consumed in Hepatocellular Carcinoma (HCC)
Figure 26. Global Atezolizumab Market: Hepatocellular Carcinoma (HCC) (2018-2023) & (K Pcs)
Figure 27. Atezolizumab Consumed in Other
Figure 28. Global Atezolizumab Market: Other (2018-2023) & (K Pcs)
Figure 29. Global Atezolizumab Sales Market Share by Application (2022)
Figure 30. Global Atezolizumab Revenue Market Share by Application in 2022
Figure 31. Atezolizumab Sales Market by Company in 2022 (K Pcs)
Figure 32. Global Atezolizumab Sales Market Share by Company in 2022
Figure 33. Atezolizumab Revenue Market by Company in 2022 ($ Million)
Figure 34. Global Atezolizumab Revenue Market Share by Company in 2022
Figure 35. Global Atezolizumab Sales Market Share by Geographic Region (2018-2023)
Figure 36. Global Atezolizumab Revenue Market Share by Geographic Region in 2022
Figure 37. Americas Atezolizumab Sales 2018-2023 (K Pcs)
Figure 38. Americas Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 39. APAC Atezolizumab Sales 2018-2023 (K Pcs)
Figure 40. APAC Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 41. Europe Atezolizumab Sales 2018-2023 (K Pcs)
Figure 42. Europe Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Atezolizumab Sales 2018-2023 (K Pcs)
Figure 44. Middle East & Africa Atezolizumab Revenue 2018-2023 ($ Millions)
Figure 45. Americas Atezolizumab Sales Market Share by Country in 2022
Figure 46. Americas Atezolizumab Revenue Market Share by Country in 2022
Figure 47. Americas Atezolizumab Sales Market Share by Type (2018-2023)
Figure 48. Americas Atezolizumab Sales Market Share by Application (2018-2023)
Figure 49. United States Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. Canada Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. Mexico Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Brazil Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 53. APAC Atezolizumab Sales Market Share by Region in 2022
Figure 54. APAC Atezolizumab Revenue Market Share by Regions in 2022
Figure 55. APAC Atezolizumab Sales Market Share by Type (2018-2023)
Figure 56. APAC Atezolizumab Sales Market Share by Application (2018-2023)
Figure 57. China Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. Japan Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. South Korea Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. Southeast Asia Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. India Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 62. Australia Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 63. China Taiwan Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 64. Europe Atezolizumab Sales Market Share by Country in 2022
Figure 65. Europe Atezolizumab Revenue Market Share by Country in 2022
Figure 66. Europe Atezolizumab Sales Market Share by Type (2018-2023)
Figure 67. Europe Atezolizumab Sales Market Share by Application (2018-2023)
Figure 68. Germany Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. France Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. UK Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 71. Italy Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 72. Russia Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 73. Middle East & Africa Atezolizumab Sales Market Share by Country in 2022
Figure 74. Middle East & Africa Atezolizumab Revenue Market Share by Country in 2022
Figure 75. Middle East & Africa Atezolizumab Sales Market Share by Type (2018-2023)
Figure 76. Middle East & Africa Atezolizumab Sales Market Share by Application (2018-2023)
Figure 77. Egypt Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 78. South Africa Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 79. Israel Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 80. Turkey Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 81. GCC Country Atezolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 82. Manufacturing Cost Structure Analysis of Atezolizumab in 2022
Figure 83. Manufacturing Process Analysis of Atezolizumab
Figure 84. Industry Chain Structure of Atezolizumab
Figure 85. Channels of Distribution
Figure 86. Global Atezolizumab Sales Market Forecast by Region (2024-2029)
Figure 87. Global Atezolizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 88. Global Atezolizumab Sales Market Share Forecast by Type (2024-2029)
Figure 89. Global Atezolizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 90. Global Atezolizumab Sales Market Share Forecast by Application (2024-2029)
Figure 91. Global Atezolizumab Revenue Market Share Forecast by Application (2024-2029)
